Glucotrack (GCTK) Notes Payables (2010 - 2025)
Glucotrack's (GCTK) quarterly Notes Payables came in at $3.2 million in Q4 2025, up 63540.0% YoY from N/an in Q4 2024, and up 4.98% on a QoQ basis from $3.0 million in Q3 2025.
Glucotrack (GCTK) Notes Payables (2010 - 2025) Analysis & Trends
Glucotrack (GCTK) has 6 years of Notes Payables data on file, last reported at $3.2 million in Q4 2025.
- Quarterly Notes Payables rose 63540.0% year-over-year to $3.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.2 million (up 63540.0% YoY) and the FY2025 annual result came in at $3.2 million, up 63540.0% from the prior year.
- Notes Payables improved to $3.2 million in Q4 2025, from $3.0 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $3.2 million in Q4 2025 to a low of $5000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn |
| 10 | Glucotrack | 1.73 Mn | 607,139.82 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.18 Mn |
| Sep 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | 9,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2014 | 23,838.00 |
| Dec 31, 2012 | 37,427.00 |
| Sep 30, 2012 | 50,980.00 |
| Mar 31, 2011 | 29,890.00 |
| Dec 31, 2010 | 18,843.00 |